4.06 (-%)
As of Feb 13, 2024
Source:
We are a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. Our development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | (857) 400-9491 |
Industry | |
CEO | Timothy Clackson |
Website | www.clinicaltrials.gov |